Moderna Begins Human Study Of MRNA-Based Flu Shot After Covid Success
Topline Moderna announced Wednesday it has dosed the first participants in a study of what the vaccine manufacturer hopes will be a more effective flu shot based on the mRNA technology used to make its uber successful Covid-19 vaccine. Key Facts The biotechnology company said in a Wednesday morning press release that the Phase 1/2…
Read More
0
